U.S. factories cut back purchases sharply,signaling heightened risks of manufacturing weakness spilling over into the broader economy in 2025
Nov 13, 2024
BEIJING,Nov. 12,2024-- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC),a one-stop AI video solution provider,recently presented at GET2024 Education Technology Con
Nov 13, 2024
New feature enables retail investors to trade 24 hours a day,5 days a week NEW YORK,Nov. 12,2024-- Webull,a leading digital investment platform,today announced the launch of Overnight Trading,powered
Nov 13, 2024
BEIJING,Nov. 12,2024-- A news report fromChina.org.cn on China-U.S. relationship:  
Nov 13, 2024
WTCA members gathered in New York to explore innovative strategies and strengthen partnerships that will enhance international business
Nov 13, 2024
Highlights: ISM001-055 was safe and well-tolerated with a favorable PK profile in IPF patients Patients who received ISM001-055 showed dose-dependent improvement in the efficacy endpoint,as measured
Nov 13, 2024
Doors close,in Rho Fiera Milano,at the 81st International two-wheeler Exhibition,with record number of exhibitors,brands and surface occupied. Great success also for the new contents of the outdoor a
Nov 13, 2024
MILPITAS,Calif.,Nov. 12,2024-- Worldwide silicon wafer shipments increased 5.9% quarter-over-quarter to 3,214 million square inches (MSI) in the third quarter of 2024 and registered 6.8% growth from
Nov 13, 2024
ONTARIO,Calif.,Nov. 13,2024-- Nature\'s Miracle Holding Inc.(NASDAQ: NMHI) ("Nature\'s Miracle" or the "Company"),today closed its previously announced underwritten public offering
Nov 13, 2024
WINAICO\'s initial actions to adhere to EU human rights protections HSINCHU,Nov. 13,2024-- Formally adopted by the European Council at the end of July 2024,the Corporate Sustainability Due Diligence D
Nov 13, 2024
Receives Novel Food approval from Food Standards Australia New Zealand (FSANZ) Recognized as an official low-calorie sweetener for use in sugar-reduced and sugar-free products
Nov 13, 2024
SUZHOU,China,Nov. 13,2024-- Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033,a high-concentration subcutaneous co-formulation consisting of an
Nov 13, 2024
© Singapore Technology Information Privacy Policy Contact us